Search INDIGO This Collection

Hematology and Oncology, Division of

Recent Additions

[2012-06-27] Long-term follow-up of HLA-A2+ patients with high-risk, hormone-sensitive prostate cancer vaccinated with the prostate specific antigen peptide homologue, PSA146-154

Perambakam, Supriya; Xie, Hui; Edassery, Seby; Peace, David J. (Hindawi Publishing Corporation, 2010)

PDF (879KB)
[2011-05-07] Outcome after reduced chemotherapy for intermediate-risk neuroblastoma

Baker, David L.; Schmidt, Mary L.; Cohn, Susan L.; Maris, John M.; London, Wendy B.; Buxton, Allen; Stram, Daniel; Castleberry, Robert P.; Shimada, Hiroyuki; Sandler, Anthony; Shamberger, Robert C.; Look, Thomas; Reynolds, Patrick; Seeger, Robert C.; Matthay, Katherine (Massachusetts Medical Society, 2010-09-30)

PDF (709KB)

Items	Views
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma	4
Long-term follow-up of HLA-A2+ patients with high-risk, hormone-sensitive prostate cancer vaccinated with the prostate specific antigen peptide homologue, PSA146-154	1

	2013-01	2013-02	2013-03	2013-04	2013-05	total
Publications Hematology and Oncology	40	44	56	79	22	241
Publications - Epidemiology and Biostatistics	20	15	19	28	9	91